Abstract
Background-Pharmacological blockade of β3-integrins inhibits neointimal lesion formation in nonmouse animal models of arterial injury. In contrast, β3-integrin-deficient (β 3-/-) mice are not protected from neointimal lesion formation after arterial injury. We investigated this discrepancy in β 3-/- and wild-type (β3+/+) mice using different models of injury. Methods and Results-After disruption of the carotid with a transluminal probe, there was no significant difference in neointimal thickening between β3-/- and β 3+/+ mice. However, after ligation of the carotid without medial disruption, there was reduced neointimal thickening in β 3-/- mice compared with β3+/+ mice at intervals up to 3 months. Lesion reduction in β3 -/- mice was associated with fewer intimal smooth muscle cells (SMCs) without a difference in SMC apoptosis or proliferation rate compared with β3+/+ mice, consistent with reduced SMC migration from the media into the intima of β3-/- mice. Moreover, combined eccentric medial disruption and ligation of the carotid in β3-/- mice resulted in neointimal lesion formation only at the site of medial disruption. Transplantation of bone marrow cells harvested from β3+/+ mice into irradiated β 3-/- mice resulted in reduced neointimal lesion formation after carotid ligation injury, confirming the importance of α vβ3 and not αIIbβ3 in the attenuated response. Conclusions-The αvβ 3-integrin mediates intimal SMC accumulation that contributes to neointimal thickening in the setting of arterial ligation.
Original language | English |
---|---|
Pages (from-to) | 1564-1569 |
Number of pages | 6 |
Journal | Circulation |
Volume | 109 |
Issue number | 12 |
DOIs | |
State | Published - Mar 30 2004 |
Keywords
- Angioplasty
- Cell adhesion molecules
- Muscle, smooth
- Restenosis